Butterfly Network Launches Next-Generation Butterfly iQ3 In The United States, Which Received FDA Clearance Last Month
Portfolio Pulse from Benzinga Newsdesk
Butterfly Network, Inc. (NYSE:BFLY) announced the commercial launch of Butterfly iQ3, a next-generation handheld ultrasound system with FDA clearance. The iQ3 features advanced P4.3 Ultrasound-on-Chip technology, offering faster data transfer, enhanced frame rates, frequency, and new 3D imaging capabilities. It is now available for purchase in the U.S. The device is designed to improve diagnostic decisions with its high-resolution image quality and advanced imaging tools, including iQ Slice and iQ Fan for 3D imaging. Butterfly iQ3 is developed in collaboration with TSMC (NYSE:TSM), leveraging their semiconductor innovation.
February 13, 2024 | 1:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Butterfly Network launched Butterfly iQ3, a next-gen handheld ultrasound system with enhanced imaging capabilities, now available in the U.S. after receiving FDA clearance.
The launch of Butterfly iQ3 represents a significant advancement in ultrasound technology, potentially increasing Butterfly Network's market share and customer base in the healthcare sector. The FDA clearance and the device's advanced features could lead to increased sales and positive market reception.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
TSMC collaborated with Butterfly Network on the development of the Butterfly iQ3, leveraging semiconductor innovation for advanced imaging capabilities.
TSMC's partnership with Butterfly Network for the development of the Butterfly iQ3 highlights its role in advancing medical technology. This collaboration could enhance TSMC's reputation in the semiconductor industry and potentially lead to further partnerships in the healthcare sector.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70